ClinicalTrials.Veeva

Menu

Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer (RESTORE-AIR)

R

Royal Marsden NHS Foundation Trust

Status and phase

Unknown
Phase 3

Conditions

Non-small Cell Lung Cancer

Treatments

Procedure: General anaesthetic
Other: Spirometry & flow volume loop assessment
Other: Walking test
Other: Venepuncture
Other: Biopsy material
Other: Arterial puncture
Procedure: Inpatient stays

Study type

Interventional

Funder types

Other

Identifiers

NCT01003522
CCR2987

Details and patient eligibility

About

To investigate whether the use of airways stents (metal tubes to open and keep open narrowed airways) together with the standard treatment increases the proportion of patients who can complete a 6min walking distance (6MWD) test at 2 weeks +/- 2days in patients with breathlessness due to lung cancer, when compared to standard treatment alone.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Able to give informed written consent in the English language
  • Able and willing to attend St Georges Hospital / Royal Marsden Hospital for stent insertion (if allocated) and documentation of 6 minute walking distance.
  • Willing to re-attend for follow-up and 6 minute walking distance at St Georges Hospital / Royal Marsden Hospital 2 weeks later (all patients)
  • Diagnosis of non-small cell lung cancer with centrally placed tumour with some degree of airway obstruction from information from bronchoscopy or CT scan.
  • ECOG Performance status: 0-3

Exclusion criteria

  • Relative contraindications to stenting, e.g. bleeding abnormality or anticoagulation problems.
  • Pregnancy
  • Radically treatable disease.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Treatment Arm A
Other group
Description:
Stenting of central lesion and subsequent standard palliative treatment and dyspnoea symptom control
Treatment:
Other: Biopsy material
Other: Arterial puncture
Procedure: Inpatient stays
Other: Walking test
Procedure: General anaesthetic
Other: Spirometry & flow volume loop assessment
Other: Venepuncture
Treatment Arm B
Other group
Description:
Standard palliative treatment and standard dyspnoea symptom control.
Treatment:
Other: Arterial puncture
Other: Walking test
Other: Spirometry & flow volume loop assessment
Other: Venepuncture

Trial contacts and locations

1

Loading...

Central trial contact

Dr Mary O'Brien

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems